Pharma heavyweights MSD (Merck) and Eisai have announced they are to join forces to develop and commercialise the latter’s tyrosine kinase inhibitor Lenvima (lenvatinib mesylate), both as a monotherapy and in...

Santhera Pharmaceuticals said a study of its medicine Raxone in primary progressive multiple sclerosis showed no difference between the treatment and placebo groups in disease progression, another setback for the Swiss...

Roche has revealed that its multiple sclerosis (MS) drug Ocrevus (ocrelizumab) has been awarded marketing approval in Europe by the European Commission.

Orexigen Therapeutics, a biotech that was one of a wave of companies bringing through weight-loss pills, has announced that it has filed for bankruptcy.

Net als ieder jaar brengen We Are Social en Hootsuite het Global Digital Report samen een rapport uit over de staat van het globale digitale landschap. Met inzichten in het gebruik van internet, social media, mobile en...